Physician profile
David A Shapiro
NPI 1285656504
$1,479.75
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,028 · 2020: $436 · 2021: $15.74.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $462.70 | 2019-2020 | |
| Lilly USA, LLC | $231.22 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $160.80 | 2020 | |
| Astellas Pharma US INC | $137.58 | 2019 | |
| Allergan, INC. | $124.08 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $79.51 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $59.52 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $55.89 | 2019 | |
| Janssen Pharmaceuticals, INC | $27.07 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.89 | 2019 | |
| Neos Therapeutics, LP | $24.71 | 2019 | |
| Pfizer INC. | $24.61 | 2019 | |
| Vertical Pharmaceuticals, LLC | $14.95 | 2019 | |
| Glaxosmithkline, LLC. | $13.29 | 2020 | |
| Amgen INC. | $12.93 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $12.74 | 2019 | |
| Amarin Pharma, INC. | $12.26 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Shapiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.